Cargando…
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy
Therapeutic response is evaluated using the diameter of tumors and quantitative parameters of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET). Tumor response to molecular-targeted drugs and immune checkpoint inhibitors is different from conventional chemotherapy in terms of...
Autores principales: | Oriuchi, Noboru, Sugawara, Shigeyasu, Shiga, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556039/ https://www.ncbi.nlm.nih.gov/pubmed/32972006 http://dx.doi.org/10.3390/biomedicines8090371 |
Ejemplares similares
-
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment
por: Oriuchi, Noboru, et al.
Publicado: (2022) -
Determination of brain tumor recurrence using (11)C‐methionine positron emission tomography after radiotherapy
por: Yamaguchi, Shigeru, et al.
Publicado: (2021) -
The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019) -
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
por: Donegani, Maria Isabella, et al.
Publicado: (2020) -
Positron emission tomography
Publicado: (1995)